REPORT ID 495

Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Report 2017

Publish Date
04-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the global Female Hypoactive Sexual Desire Disorder Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Female Hypoactive Sexual Desire Disorder Therapeutics for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Female Hypoactive Sexual Desire Disorder Therapeutics market competition by top manufacturers/players, with Female Hypoactive Sexual Desire Disorder Therapeutics sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Emotional Brain BV
    GlaxoSmithKline Plc
    Palatin Technologies Inc
    Pivot Pharmaceuticals Inc
    Strategic Science & Technologies LLC
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    BP-101
    Bremelanotide
    Gepirone Hydrochloride ER
    PVT-011
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Out-Patient
    In-Patient

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Report 2017
1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Overview
    1.1 Product Overview and Scope of Female Hypoactive Sexual Desire Disorder Therapeutics
    1.2 Classification of Female Hypoactive Sexual Desire Disorder Therapeutics by Product Category
        1.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 BP-101
        1.2.4 Bremelanotide
        1.2.5 Gepirone Hydrochloride ER
        1.2.6 PVT-011
        1.2.7 Others
    1.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application/End Users
        1.3.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Out-Patient
        1.3.3 In-Patient
    1.4 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market by Region
        1.4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2012-2022)
        1.4.3 China Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2012-2022)
        1.4.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2012-2022)
        1.4.5 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2012-2022)
        1.4.7 India Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Female Hypoactive Sexual Desire Disorder Therapeutics (2012-2022)
        1.5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2012-2022)

2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Competition by Players/Suppliers, Type and Application
     2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Competition by Players/Suppliers
        2.1.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics (Volume and Value) by Type
        2.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Market Share by Type (2012-2017)
        2.2.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Market Share by Type (2012-2017)
    2.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics (Volume and Value) by Region
        2.3.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Market Share by Region (2012-2017)
        2.3.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Market Share by Region (2012-2017)
    2.4 Global Female Hypoactive Sexual Desire Disorder Therapeutics (Volume) by Application

3 United States Female Hypoactive Sexual Desire Disorder Therapeutics (Volume, Value and Sales Price)
    3.1 United States Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Value (2012-2017)
        3.1.1 United States Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Growth Rate (2012-2017)
        3.1.2 United States Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2012-2017)
        3.1.3 United States Female Hypoactive Sexual Desire Disorder Therapeutics Sales Price Trend (2012-2017)
    3.2 United States Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Players
    3.3 United States Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Type
    3.4 United States Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Application

4 China Female Hypoactive Sexual Desire Disorder Therapeutics (Volume, Value and Sales Price)
    4.1 China Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Value (2012-2017)
        4.1.1 China Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Growth Rate (2012-2017)
        4.1.2 China Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2012-2017)
        4.1.3 China Female Hypoactive Sexual Desire Disorder Therapeutics Sales Price Trend (2012-2017)
    4.2 China Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Players
    4.3 China Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Type
    4.4 China Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Application

5 Europe Female Hypoactive Sexual Desire Disorder Therapeutics (Volume, Value and Sales Price)
    5.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Value (2012-2017)
        5.1.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Growth Rate (2012-2017)
        5.1.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Sales Price Trend (2012-2017)
    5.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Players
    5.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Type
    5.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Application

6 Japan Female Hypoactive Sexual Desire Disorder Therapeutics (Volume, Value and Sales Price)
    6.1 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Value (2012-2017)
        6.1.1 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Growth Rate (2012-2017)
        6.1.2 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Sales Price Trend (2012-2017)
    6.2 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Players
    6.3 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Type
    6.4 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Application

7 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics (Volume, Value and Sales Price)
    7.1 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Value (2012-2017)
        7.1.1 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Sales Price Trend (2012-2017)
    7.2 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Players
    7.3 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Type
    7.4 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Application

8 India Female Hypoactive Sexual Desire Disorder Therapeutics (Volume, Value and Sales Price)
    8.1 India Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Value (2012-2017)
        8.1.1 India Female Hypoactive Sexual Desire Disorder Therapeutics Sales and Growth Rate (2012-2017)
        8.1.2 India Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2012-2017)
        8.1.3 India Female Hypoactive Sexual Desire Disorder Therapeutics Sales Price Trend (2012-2017)
    8.2 India Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Players
    8.3 India Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Type
    8.4 India Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Market Share by Application

9 Global Female Hypoactive Sexual Desire Disorder Therapeutics Players/Suppliers Profiles and Sales Data
    9.1 Emotional Brain BV
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Female Hypoactive Sexual Desire Disorder Therapeutics Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 GlaxoSmithKline Plc
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Female Hypoactive Sexual Desire Disorder Therapeutics Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Palatin Technologies Inc
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Female Hypoactive Sexual Desire Disorder Therapeutics Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Pivot Pharmaceuticals Inc
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Female Hypoactive Sexual Desire Disorder Therapeutics Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Strategic Science & Technologies LLC
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Female Hypoactive Sexual Desire Disorder Therapeutics Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    ...

10 Female Hypoactive Sexual Desire Disorder Therapeutics Maufacturing Cost Analysis
    10.1 Female Hypoactive Sexual Desire Disorder Therapeutics Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Female Hypoactive Sexual Desire Disorder Therapeutics
    10.3 Manufacturing Process Analysis of Female Hypoactive Sexual Desire Disorder Therapeutics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Female Hypoactive Sexual Desire Disorder Therapeutics Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Female Hypoactive Sexual Desire Disorder Therapeutics Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast (2017-2022)
    14.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics Price and Trend Forecast (2017-2022)
    14.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Female Hypoactive Sexual Desire Disorder Therap